Pushpawati Singhania Research Institute aims at providing Targeted Therapy using advanced precision medicine technology and patient-centric oncology care techniques. The NABH, NABL accredited hospital was established in 1996 in Delhi, India and has 201 beds to care for both domestic and international patients.

Targeted Therapy is a treatment option that targets specific human DNA and proteins that play a critical role in the growth and survival of cancerous cells. The therapy can be used as a standalone treatment or in combination with chemotherapy, radiotherapy, and other medications, depending on the patient's diagnostic results. Before proceeding with a treatment, medical experts conduct biopsy analyses and molecular tests to identify which treatment is most effective.